2. The antibody of claim 1 which is a murine monoclonal antibody.

treatment of Crohn's disease.

6. The antibody of claim 5 which is a murine monoclonal antibody.

6. The antibody of claim 5 which is a murine monoclonal antibody.

as determined by polyacrylamide gel electrophoresis, said cytotoxin being obtainable from stimulated human monocytes, said cytotoxin being further characterized by exhibiting a cytotoxic effect on cycloheximide-sensitized SV-80 cells and by being obtainable in a state of enhanced purity by adsorption of the cytotoxin from an impure preparation onto controlled pore glass beads, and subsequent desorption of the cytotoxin in a state of enhanced purity

A monoclonal antibody

are being treated for an infection, or get a lot of infections or have infections that keep coming back have diabetes, HIV, or a weak immune system. People with these conditions have a higher chance for infections. have tuberculosis (TB), or have been in close contact with someone with TB were born in, lived in, or traveled to countries where there is more risk of getting TB. Ask your healthcare provider if you are not sure. live or have lived in certain parts of the country (such as the Ohio and Mississippi River valleys) where there is an increased risk for getting certain kinds of fungal infections (histoplasmosis, coccidioidomycosis, blastomycosis). These infections may develop or become more severe if you take CIMZIA. If you do not know if you have lived in an area where histoplasmosis, coccidioidomycosis, or blastomycosis is common, ask your healthcare provider. have or have had hepatitis B

It is a fragment of a monoclonal antibody

molecular weight of about 17,500 as determined by polyacrylamide gel electrophoresis

a human cytotoxin having a molecular weight of about 17,500

monoclonal antibody which specifically binds a human cytotoxin